Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe observed changes consist mainly of formatting adjustments and minor content updates on the study page, with no alterations to core details such as eligibility criteria, primary outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check23 days agoChange DetectedAdded a new reference to a study on avacopan for ANCA-associated vasculitis (ADVOCATE Study Group) with full citation and DOI.SummaryDifference0.8%

- Check30 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.SummaryDifference2%

- Check38 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page updates from revision v3.0.1 to v3.0.2. No substantive changes to core content or availability; only a version tag update and removal of the Back to Top element.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.